Investigation of 100 consecutive negative cone biopsies

Size: px
Start display at page:

Download "Investigation of 100 consecutive negative cone biopsies"

Transcription

1 British Journal of Obstetrics and Gynaecology January 1997, Vol. 104, pp Investigation of 100 consecutive negative cone biopsies *Pouran Golbang Research Fellow and Consultant (Gynaecology), **James Scurry Consultant (Histopathology), **Sarah de Jong Medical Scientist, * *Dominique McKenzie Cytologist, *Robert Planner Consultant (Gynaecology),?Jan Pyman Consultant (Histopathology), TtRuth Davoren Consultant (Histopathologist) Departments of +Oncology and **Pathology, Mercy Hospital for Women, t Kctorian Cytology Service and YfCytopath Histology and Cytologv, Melbourne, Australia Objective To investigate the reasons for cone biopsies reported as not containing intraepithelial or invasive malignancy and thereby find ways to decrease their incidence. Design One hundred cone biopsies reported as negative were identified out of a total of 436 consecutive cone biopsies. The patients cytology, colposcopy and histology reports and cytology and histology slides were reviewed. Further opinions in cases of doubt were obtained in cytology and histology. In cone biopsies still considered negative after reviews, deeper levels were cut, exhausting all paraffin blocks. Follow up cytology, colposcopy and histology were reviewed. Setting Gynaecological oncology unit in a university teaching hospital. Results After re-evaluation the final diagnoses of cone biopsies initially reported as negative were positive (n = 21), unsatisfactory (n = 27) and true negative (n = SI), with one case excluded because of insufficient material for review. The positive cases were diagnosed on review (n = 11) or extra levels (n = 10). The unsatisfactory cases were all due to denudation. The 5 1 true negative cases were divided into those which never had had histologic confirmation by punch biopsy or endocervical curettage (n = 47) and those with a previously confirmed histological abnormality (n = 4). Conclusions The number of negative cone biopsies can be reduced by: 1. taking Pap smears after correction of atrophy and inflammation; 2. more scrupulous colposcopy aimed at reducing the number of unsatisfactory colposcopies or misinterpreted colposcopic findings; this thorough examination should include the vagina and vulva; 3. confirmation of smear and colposcopic findings by biopsy prior to cold-knife conisation and performing a large loop excision of the transformation zone (LLETZ) for cases where there is a discrepancy between the smear abnormality and colposcopy/biopsy findings; 4. good quality cone biopsies using a technique that does not handle the mucosa and is performed after the mucosa has had time to regenerate following the colposcopic investigations; and 5. exhausting all blocks with multiple levels before reporting a cone biopsy as negative. INTRODUCTION The traditional management of preinvasive disease of the cervix begins with an abnormal smear detected on routine screening. The patient is referred to a colposcopist who attempts to grade, delineate and biopsy the abnormality. A colposcopic-directed biopsy confirms the smear and colposcopic diagnoses and, at a second visit, the abnormal transformation zone is destroyed. Where there is suspicion of invasion or adenocarcinoma in situ or an unsatisfactory colposcopy (defined as an inability to see the full transformation zone, the endocervical limits of a lesion or a discrepancy between the smear and colposcopic findings) a cone biopsy is performed. Correspondence: Dr J. Scurry, Department of Pathology, Mercy Hospital for Women, Clarendon Street, East Melbourne, Victoria 3002, Australia. The cone biopsy usually provides a definitive diagnosis, with type, grade, extent of the lesion and state of the resection lines. Not infrequently, however, no lesion is found on histological examination of the cone biopsy. There are many potential reasons for negative cone biopsies, including misreporting of cytology, colposcopy and/or histology, denudation of the mucosa or abnormal cells translocated from elsewhere in the genital tract accounting for the original smear diagnosis. Negative cone biopsies are unsatisfactory to both clinician and patient. While one important benefit is the virtual exclusion of invasive cervical cancer, the abnormal cytology still has to be explained, and difficulties can develop during follow up because of stenosis of the endocervical canal, particularly in postmenopausal women. Further operations, such as dilatation of the endocervical canal and/or hysterectomy, should be considered. While cone biopsy RCOG 1997 British Journal of Obstetrics and Gynaecology

2 NEGATIVE CONE BIOPSIES 101 is a relatively safe procedure, there are possible complications of excessive haemorrhage, general anaesthetic risks and cervical incompetence with future pregnancy losses. In recent years the loop biopsy has replaced cold-knife conisation for certain indications and has the advantage that it can be performed under local anaesthetic, however, a negative loop biopsy poses similar problems in management to a negative cold knife cone biopsy. Although there have been studies reporting the incidence of negative cone biopsies as 45% to 64% depending on the indication for cone biopsy, there is only one published study of which we are aware that investigates negative cone biopsies4. Luesley et al. compared the results of pre-cone investigations in patients with positive and negative cone biopsies and found that a colposcopic suspicion of invasion, a positive pre-cone smear, two severely dyskaryotic smears within a 12 month period, previous abnormal histology and previous treatment for cervical intraepithelial neoplasia could be used to predict the presence of intraepithelial neoplasia or invasive malignancy in the cone biopsy. Conversely, 44% of negative cones could be avoided without overlooking any cases of micro- or occult invasive carcinoma. We have reviewed all cytology, histology and follow up and, where relevant, cut deeper levels of histology blocks in 100 consecutive patients with reported negative cone biopsies in an effort to determine the reasons for the negative result and thereby make recommendations on how their incidence can be reduced in the future. METHODS The reports of all patients who underwent a coldknife cone biopsy at the Mercy Hospital for Women beginning January 1989 were examined to locate 100 consecutive negative cone biopsy reports. Reports were classified as positive if they contained intraepithelial or invasive neoplasia and negative if they did not. By August 1994, after examining 436 reports, 100 negative cone biopsy reports were identified, giving a crude negative cone rate of 23%. All available cytology reports and slides, colposcopy reports, histology reports and slides of each patient with a negative cone biopsy report were reviewed. During the period of study, the standard protocol had been to open the cone biopsy in the midline anteriorly, slice it into multiple blocks 2-3 mm thick and cut three levels at 200 pm intervals from each block. The review process was performed by pathologists and cytologists who knew that they were reviewing cases in a negative cone study. There were no positive or negative controls in the review Table 1. Protocol for follow up of cone biopsies. For patients with negative cone biopsies the three-month visit includes an extra colposcopy to exclude vaginal abnormality. After three negative Pap smears, patients revert to an annual Pap smear. Time Procedure 6 weeks Routine post-operative visit 3 months Pap smear 6 months 12 months Colp and Pap smear, biopsy if indicated Pap smear process. Intra-observer variation in cytology or histology was not able to be assessed as the smears and cone biopsies were largely reviewed by different personnel than originally reported. The following information was recorded for each patient: 1. The original and review cytological prediction. 2. The colposcopic findings. 3. The original and review diagnoses of all target biopsies, endocervical and uterine curettings and cone biopsies. 4. Further opinions on the cone biopsies with difficulties in diagnosis. The paraffin blocks of the cone biopsies that were still considered negative after review and second opinion were then cut into multiple further levels, also at 200 pm intervals, until all blocks were exhausted and these extra levels examined. In cases that were still negative after these steps, it was noted in the cone biopsy whether the transformation zone was present and whether there was significant denudation or other factors hampering interpretation. The follow up cytology, colposcopy and histology reports and slides were reviewed for each case. Patients who have a cone biopsy at Mercy Hospital are followed up according to the protocol shown in Table 1. At the conclusion of the review process the cone biopsies were given a final diagnosis ofpositive if intraepithelial or invasive neoplasia was found on review, further opinion or deeper levels, unsatisfuctory if the entire squamocolumnar junction was not present in the slides or negative if none of the above were found. RESULTS The final diagnoses of the cone biopsies after investigations are given in Table 2. Note that one case was excluded because of lack of material for review. Positive There were 2 1 positive diagnoses. Inter-observer variation of opinion on the histology of cone biopsies occurred in 11 cases: in five patients the reviewing

3 102 P. GOLBANG ET AL Table 2. Final histological diagnoses of 100 negative cone biopsies after review and deeper levels. One case was excluded because of a lack of material for review, therefore total n = 99. Positive Unsatisfactory Diagnosis changed Denudation on review (n = 5) (n = 27) Diagnosis changed on second opinion (n = 6) Diagnosis changed on extra levels (n = 10) n=21 n=27 True Negative Non-histologically confirmed pap smear abnormality (n = 47) Histologically confirmed abnormality (n = 4) Abnormality on follow up (n = 3) n=51 pathologist (J.S.) and in six the second opinion pathologist (R.D.) reclassified the cone biopsies as showing intraepithelial neoplasia. Difficulties distinguishing atrophic, inflammatory and/or metaplastic changes from intraepithelial neoplasia accounted for the differences in opinion between pathologists in all cases. Between three and eight extra levels (mean extra 4.2 levels) were cut on each block of each cone biopsy that was still negative after review and second opinion. Examination of these extra levels led to the diagnosis of another ten cases with intraepithelial neoplasia. Unsatisfactory There were 27 women whose cone biopsies showed denudation involving the squamocolumnar junction in at least one block, and nearly all of these had denudation involving multiple blocks. This epithelial stripping was particularly related to conisation using a technique which involved probing the endocervical canal. Opening the unfixed cone biopsy in the laboratory may have been another factor. True negative The 51 cone biopsies which remained negative after reviews and extra levels and had a full covering of epithelium for assessment were called true negative cones. In this group, the age range was 24 to 72 years (mean 50.6); menopausal status was not recorded. The duration of the cytological abnormality before conisation was less than six weeks in 8 patients, six weeks to three months in 11, greater than three months in 13 and not known in 19. The interval between colposcopy and cone biopsy was less than six weeks in 32 patients, six weeks to three months in 5, greater than three months in 3 and not known in 11. The true negative cone patients were divided into thqse which had a histologically confirmed abnormality (n = 4) and those that did not (n = 47). True negative cone biopsies with histologically confirmed abnormality Three of the four patients with negative cone biopsies had small lesions seen at colposcopy and confirmed high grade cervical intraepithelial neoplasia (CIN) on biopsy, suggesting that the biopsy removed the CIN before the cone biopsy. Another patient with referral and colposcopic smear showing CIN 2, had a normal colposcopy, but CIN 1-2 on endocervical curetting, again suggesting that the abnormality was removed by curettage. True negative cones without histologically confirmed abnormality The cone biopsies in these 47 patients were performed on the basis of an abnormal smear and a positive or unsatisfactory colposcopy. The original diagnoses of the first smear abnormality were high grade abnormality in 23 women, low grade or negative in 15 and inconclusive in two. The results of smears in seven women were not available. These referral smears were available in 23 women for review. The review diagnoses were high grade abnormality in six women, low grade or negative in ten and inconclusive in seven. Colposcopic smears were reviewed in 31 patients. The review diagnoses were high grade abnormality in only six women and low grade or negative in 25. Of 39 colposcopies whose results were available for review, high grade abnormalities were diagnosed in only eight. Biopsies and endocervical curettage were performed in 21 women, and none had proven high grade abnormality. The cone biopsies in 18 patients showed benign changes (e.g. atrophy, inflammation, immature metaplasia, basal cell hyperplasia and HPV) that were difficult to distinguish from intraepithelial neoplasia. When the original Papanicolaou (Pap) smears were reviewed in conjunction with these 18 cone biopsies, the benign changes at least partly explained the Pap smear findings. One woman had a history of carcinoma of the breast; she had a cone biopsy for an abnormal looking cervix on colposcopy, despite a normal smear, but no abnormality was predicted in the cone biopsy and none was found. Follow up Eighty-eight patients were followed up at Mercy Hospital from six months to five years. At the time of writing, none of them has developed an invasive carcinoma of the cervix. A total of 276 smears, 87 colposcopies and 25 biopsy procedures have been performed in follow up. Of the patients with true 0 RCOG 1997 Br J Obstet GynaecoZlO4,

4 NEGATIVE CONE BIOPSIES 103 negative cone biopsies, two had vaginal intraepithelial neoplasia, one had CIN on repeat cone biopsy following further abnormal smears, and one had endometrial carcinoma who had had a glandular cell abnormality reported on original Pap smear. A fifth patient who had a positive cone biopsy also developed vaginal intraepithelial neoplasia and a sixth patient with a denuded cone biopsy had CIN diagnosed on follow up smear and confirmed histologically. DISCUSSION The crude negative cone rate in this study was 23%; however, after investigation and exclusion of positive and unsatisfactory cases, the true negative cone rate fell to 11.7%, which is comparable to the negative cone rates in other studies of random cone bi~psies~-~. Positive cases Inter-observer variation of opinion in 1 1 cases (1 1%) reflected difficulties for histopathologists in distinguishing atrophy, inflammatory change, metaplasia and basal cell hyperplasia from intraepithelial neoplasia. The finding of intraepithelial neoplasia in deeper levels in 10 cases (1 0%) indicates that a negative cone biopsy report should not be issued until deeper levels have been cut, exhausting all blocks. The practice of cutting three levels at 200 pm intervals examines less than one third of a 2 mm thick block. Unsatisfactory cases Denudation was found in 27 negative cone biopies preventing complete assessment of the transformation zone. It is incorrect to assume that a denuded specimen is normal as dysplastic epithelium is easily stripped at the time of conisation. Twenty-seven percent unsatisfactory specimens in a procedure that is essentially diagnostic is disappointingly high, but there are no figures in the literature with which we can compare this. The strict criterion for inclusion into this category of only one slide showing loss of epithelium at the squamocolumnar junction may account for the high number of unsatisfactory cases. Damage to the epithelium can occur before, during and after conisation. At colposcopy, rough handling, smear taking, endocervical curettage and biopsies all damage epithelium. Enough time must be given for the epithelium to heal between colpscopy and conisation. During conisation, probing the cervical canal before cutting the cone biopsy was a potent cause of denudation in our study. Rough handling of the specimen in the laboratory was another possible cause of denudation. The blocking of the cone specimen by the pathologist should involve a technique that does not handle the mucosa. We now fix the cone biopsy whole and cut the cone after fixation into sequential parasagittal slices 2-3 mm thick after painting the stromal resection lines and find this preferable to our previous technique of opening the cone in the fresh state, pinning it out on cork board, fixing it and then slicing it into multiple longitudinal blocks. True negative In this study a small area of abnormal epithelium would appear to have been completely removed by biopsy and/or endocervical curettage in four cases. There are a number of possible reasons why a biopsy-proven abnormality is not found in the cone biopsy including complete removal by biopsy, pregnancy, delivery and regressions. A much greater problem were the 47 patients with true negative cone biopsies who had not had their smear predictions confirmed as histological abnormalities. This group had a mean age of 50.6 years, significantly older than the mean age of 39 years reported for the group in the large study by Luesley et al4 of 899 patients with cone biopsies. Older women are liable to have atrophic changes on smears which could be confused with intraepithelial neoplasia as well as unsatisfactory colposcopy due to inversion of the squamocolumnar junction and atrophic changes in the mucosa. Furthermore, 68% had their cone biopsies less than six weeks after colposcopy. Performing a cone biopsy soon after colposcopy, if not denuding the transformation zone, gives the pathologist the problem of distinguishing degenerative and regenerative changes from intraepithelial neoplasia in the cone biopsy. In the patients with true negative cone biopsies, the minimum indication for cone biopsy was a smear abnormality with an unsatisfactory colposcopy. Misinterpretation of cytology could be a very important reason for the performance of negative cone biopsies. While there has been great emphasis on false negative smears, false positive smears have not attracted as much attention in the literature. A negative cone biopsy study is biased to show a high rate of false positive Pap smears. In this study the referral Pap smears of five patients with true negative cone biopsies were considered on review to be overcalled. Three were judged false positives and two downgraded from high grade to low grade abnormality. The reasons for overcall were atrophy, inflammation, metaplasia, high endocervical canal sample and

5 104 P. GOLBANG ET AL difficulty in diagnosing glandular lesions. The annual report of the Victorian Cervical Cytology Register (1994) compared the results of cytology and corresponding histology/ colposcopy findings. On cytology, 37% of biopsies were reported as normal for atypiahuman papillomavirus reported, for CIN 1 as 19%, for CIN 2 as 11% and for CIN 2-3 as 7%6. Although these statistics also suggest a high rate of false positive cytology, it should be kept in mind that the biopsies were target biopsies of an abnormal area found at colposcopy. Wrong site of sampling and poor sampling techniques could have contributed to these high rates. Adenocarcinoma in situ is a particular problem. In this study eight patients with true negative cones had a smear and/or colposcopic suggestion of adenocarcinoma in situ, the diagnosis of which can be difficult on Pap smear and colposcopy. If this is suggested on smear, patients generally proceed to cone biopsy irrespective of colposcopy and biopsy findings and the suspicion of this condition would appear to account for an unavoidable cause of negative cone biopsies. Colposcopy has greatly reduced the need for cone biopsy7, but unsatisfactory colposcopies are a major problem. Of the 42 colposcopies in the true negative group where the findings were available for review, 35 (82%) were unsatisfactory, comprising eight women whose transformation zone was not seen, 12 in whom the limits of an abnormality were not seen and 15 in whom there was a discrepancy between cytology and colposcopy or biopsy findings. Unsuccessful colposcopy is particularly prone to occur in older women in whom the transformation zone tends to retract into the endocervical canal. Successful colposcopy depends on the experience of the operator. Complete and careful examination with the use of special devices such as the endocervical and vaginal wall specula and the liberal use of acetic acid and iodine (in patients without atrophy) to mark abnormal areas will help achieve successful colposcopic examination. Even when the transformation zone can be fully visualised through the colposcope, atrophy due to menopause, postpartum status, and to a lesser extent long term use of oral contraceptives (especially progesterone-dominant types) and inflammation may be confused with a major abnormality. Stromal decidualisation in pregnancy may also cause diagnostic problems. Treatment of atrophy with oestrogen locally and/or systemically is important to reduce atrophy. Treatment of infectious conditions with appropriate antibiotics is also beneficial, although inflammation of the cervix is often not caused by treatable pathogens which respond to treatment. Awareness of changes associated with pregnancy also helps reduce diagnostic error in colposcopy, At colposcopy it is essential to examine all of the possible sites of origin of cytologic abnormality including the vagina and vulva. In two women with true negative cone biopsies in this study, vaginal intraepithelial neoplasia was found in follow up after a negative cone biopsy. Perhaps cone biopsy could have been avoided if vaginal intraepithelial neoplasia had been diagnosed at colposcopy. The most important messages to be read from this study are that the incidence of negative cone biopsies can be reduced by attention to detail at all steps in the work-up of a smear abnormality and that the patient most liable to have a negative cone is the older woman with an atrophic cervix, where smear interpretation is difficult and colposcopy unsatisfactory. References Moore EJ, Fitzpatrick CC, Coughlan BM. et al. Cone biopsy: a review of 112 cases. Ir Med J 1992; 85: Lopes A, Pearson SE, Mor-Yosef S et al. Is it time for the reconsideration of the criteria for cone biopsy. Br J Obstet Gynaecol 1989; Howel R, Hammond R, Pryse-Davies J. The histologic reliability of laser cone biopsy. Obstet Gynecoll991; 77: Luesley DM, Wade-Evans T, Jordan JA, Woodman CBJ. Negative cone biopsies and their prediction. Br J Obstet Gynaecol 1987; 94: Fletcher A, Metaxas N, Grubb C et al. Four and a half year follow up of women with dyskaryotic cervical smears. BMJ 1990; 301: Mitchell H, Higgins V. Victorian Cervical Cytologv Register. Statistical Report, Melbourne, Australia: VCCR, Benedict JL, Anderson G, H,, Simpson ML. et al. Colposcopy, conization and hysterectomy practices: A current perspective. Obstet Gynecoll982; 60: Received 5 March I996 Accepted I5 July 1996

Cervical Conization. 1

Cervical Conization.   1 Cervical Conization www.zohrehyousefi.com 1 Cone Biopsy is a surgical procedure with removal of a cone shaped portion of the cervix The extent of involvement of epithelium on the ectocervix has been clearly

More information

Faculty Pap Smear Guidelines: Family Planning Update 2008 Part Two

Faculty Pap Smear Guidelines: Family Planning Update 2008 Part Two Faculty Pap Smear Guidelines: Family Planning Update 2008 Part Two Seshu P. Sarma, MD, FAAP Emory University Regional Training Center Atlanta, Georgia Produced by the Alabama Department of Public Health

More information

Clinical Guidance: Recommended Best Practices for Delivery of Colposcopy Services in Ontario Best Practice Pathway Summary

Clinical Guidance: Recommended Best Practices for Delivery of Colposcopy Services in Ontario Best Practice Pathway Summary Clinical Guidance: Recommended Best Practices for Delivery of Colposcopy Services in Ontario Best Practice Pathway Summary Glossary of Terms Colposcopy is the examination of the cervix, vagina and, in

More information

Efficacy of cervical intrarepithelial neoplasia (CIN)

Efficacy of cervical intrarepithelial neoplasia (CIN) The Ulster Medical Journal, Volume 72, No. 1, pp. 10-15, May 2003. Efficacy of cervical intrarepithelial neoplasia (CIN) treatment by cold coagulation A Zawislak, J H Price, H R McClelland, R G N Storey,

More information

Management of Abnormal Cervical Cytology and Histology

Management of Abnormal Cervical Cytology and Histology Management of Abnormal Cervical Cytology and Histology Assoc. Prof. Gökhan Tulunay Etlik Zübeyde Hanım Women s Diseases Teaching & Research Hospital Gynecologic Oncology Clinic Universally accepted guideline

More information

Appropriate Use of Cytology and HPV Testing in the New Cervical Cancer Screening Guidelines

Appropriate Use of Cytology and HPV Testing in the New Cervical Cancer Screening Guidelines Appropriate Use of Cytology and HPV Testing in the New Cervical Cancer Screening Guidelines Tim Kremer, MD Ralph Anderson, MD 1 Objectives Describe the natural history of HPV particularly as it relates

More information

Management that provides continuity of care for women

Management that provides continuity of care for women Management that provides continuity of care for women If women are diagnosed with reproductive tract infection, prompt treatment should be instituted according to the WHO guidelines. Though it may be preferred

More information

!"#$%&'(#)*$+&,$-&.#,$/#0()1-$ ),1')$2(%&,2#,%$%(0'#$34567$

!#$%&'(#)*$+&,$-&.#,$/#0()1-$ ),1')$2(%&,2#,%$%(0'#$34567$ !"#$%&'(#)*$+&,$-&.#,$/#0()1-$ ),1')$2(%&,2#,%$%(0'#$34567$ Updated Consensus Guidelines for Managing Abnormal Cervical Cancer Screening Tests and Cancer Precursors American Society for and Cervical Pathology

More information

Treatment of Cervical Intraepithelial Neoplasia. Case. How would you manage this woman?

Treatment of Cervical Intraepithelial Neoplasia. Case. How would you manage this woman? Treatment of Cervical Intraepithelial Neoplasia Karen Smith-McCune Professor, Department of Obstetrics, Gynecology and Reproductive Sciences I have no conflicts of interest Case How would you manage this

More information

Chapter 10: Pap Test Results

Chapter 10: Pap Test Results Chapter 10: Pap Test Results On completion of this section, the learner will be able to: 1. Identify how Pap test results are interpreted and the reasons for normal and abnormal results. 2. Describe the

More information

The society for lower genital tract disorders since 1964.

The society for lower genital tract disorders since 1964. The society for lower genital tract disorders since 1964. Updated Consensus Guidelines for Managing Abnormal Cervical Cancer Screening Tests and Cancer Precursors American Society for and Cervical Pathology

More information

cle Modern management of abnormal cervical smear Tint Tint Wai and Dilip Patil BJMP 2008:1(2) 18-22

cle Modern management of abnormal cervical smear Tint Tint Wai and Dilip Patil BJMP 2008:1(2) 18-22 BJMP 2008:1(2) 18-22 Review Articl cle Modern management of abnormal cervical smear Tint Tint Wai and Dilip Patil Abbreviations BSCCP British Society of Colposcopy and Cervical Pathology CIN Cervical intraepithelial

More information

Cervical Skills. Dr Margaret Laing Queen Elizabeth University Hospital

Cervical Skills. Dr Margaret Laing Queen Elizabeth University Hospital Cervical Skills Dr Margaret Laing Queen Elizabeth University Hospital What is screening? Screening is a test offered to an apparently well person with the possibility of detecting a serious disease before

More information

CPC on Cervical Pathology

CPC on Cervical Pathology CPC on Cervical Pathology Dr. W.K. Ng Senior Medical Officer Department of Clinical Pathology Pamela Youde Nethersole Eastern Hospital Cervical Smear: High Grade SIL (CIN III) Cervical Smear: High Grade

More information

Cervical Dysplasia and HPV

Cervical Dysplasia and HPV Cervical Dysplasia and HPV J. Anthony Rakowski D.O., F.A.C.O.O.G. MSU SCS Board Review Coarse HPV Double stranded DNA virus The HPV infect epithelial cells of the skin and mucous membranes Highest risk

More information

Colposcopy. Attila L Major, MD, PhD

Colposcopy. Attila L Major, MD, PhD Colposcopy Attila L Major, MD, PhD Histology Colposcopy Cytology It has been estimated that annual Pap smear testing reduces a woman s chance of dying of cervical cancer from 4 in 1000 to about 5 in 10,000

More information

Cytology/Biopsy/Leep Gynecologic Correlation: Practical Considerations and Approaches.

Cytology/Biopsy/Leep Gynecologic Correlation: Practical Considerations and Approaches. Cytology/Biopsy/Leep Gynecologic Correlation: Practical Considerations and Approaches. Fadi W. Abdul-Karim MD MEd. Professor of Pathology. Vice chair for education. Robert Tomsich Pathology and Lab Med

More information

Running head: EVIDENCE-BASED MEDICINE TWO-STEP DISCREPANCY

Running head: EVIDENCE-BASED MEDICINE TWO-STEP DISCREPANCY Evidence-Based Medicine Two-Step Discrepancy 1 Running head: EVIDENCE-BASED MEDICINE TWO-STEP DISCREPANCY Evidence-Based Medicine Two-Step Discrepancy Julie Nelson Texas Woman s University Philosophy of

More information

Glandular Atypia In Cervical Smear: Cytohistologic And Clinical Correlation. K Elsapagh, S Swain, S Ghosh, H Dunsmore, K McMullen, J Steven, K Morton

Glandular Atypia In Cervical Smear: Cytohistologic And Clinical Correlation. K Elsapagh, S Swain, S Ghosh, H Dunsmore, K McMullen, J Steven, K Morton ISPUB.COM The Internet Journal of Gynecology and Obstetrics Volume 5 Number 2 Glandular Atypia In Cervical Smear: Cytohistologic And Clinical Correlation K Elsapagh, S Swain, S Ghosh, H Dunsmore, K McMullen,

More information

I have no financial interests in any product I will discuss today.

I have no financial interests in any product I will discuss today. Cervical Cancer Screening Update and Implications for Annual Exams George F. Sawaya, MD Professor Department of Obstetrics, Gynecology and Reproductive Sciences Department of Epidemiology and Biostatistics

More information

The routine use of ZedScan within one colposcopy service in England. MC Macdonald, R Lyon, JE Palmer, JA Tidy

The routine use of ZedScan within one colposcopy service in England. MC Macdonald, R Lyon, JE Palmer, JA Tidy The routine use of ZedScan within one colposcopy service in England MC Macdonald, R Lyon, JE Palmer, JA Tidy Introduction Colposcopic impression alone has been shown to be subjective with variable rates

More information

Management Algorithms for Abnormal Cervical Cytology and Colposcopy

Management Algorithms for Abnormal Cervical Cytology and Colposcopy Management Algorithms for Abnormal Cervical Cytology and Colposcopy Table of Contents Standard Colposcopic Definitions... 1 Guidelines for the Assessment of Abnormal Cervical Cytology... 2 Ia: Persistent

More information

Understanding Your Pap Test Results

Understanding Your Pap Test Results Understanding Your Pap Test Results Most laboratories in the United States use a standard set of terms called the Bethesda System to report pap test results. Normal: Pap samples that have no cell abnormalities

More information

Cryotherapy has No Place in Colposcopy Practice

Cryotherapy has No Place in Colposcopy Practice Cryotherapy has No Place in Colposcopy Practice No financial disclosures No conflicts of interest ? Precision? Personalized Medicine? Best Evidence Based Practice Prinicipals of Surgical Management CIN1

More information

Sydney Gynaecology Oncology Group, Sydney Cancer Centre, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia

Sydney Gynaecology Oncology Group, Sydney Cancer Centre, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia bs_bs_banner doi:10.1111/jog.12545 J. Obstet. Gynaecol. Res. Vol. 41, No. 3: 440 444, March 2015 Abnormal cervicovaginal cytology, unsatisfactory colposcopy and the use of vaginal estrogen cream: An observational

More information

Cervical Precancer: Evaluation and Management

Cervical Precancer: Evaluation and Management TAJ June 2002; Volume 15 Number 1 ISSN 1019-8555 The Journal of Teachers Association RMC, Rajshahi Review fam Cervical Precancer: Evaluation and Management SM Khodeza Nahar Begum 1 Abstract Carcinoma of

More information

Lessons From Cases of Screened Women Who Developed Cervical Carcinoma

Lessons From Cases of Screened Women Who Developed Cervical Carcinoma Lessons From Cases of Screened Women Who Developed Cervical Carcinoma R. Marshall Austin MD,PhD Magee-Womens Hospital of University of Pittsburgh Medical Center raustin@magee.edu Why Focus Study On Cases

More information

PRE TEST CERVICAL SCREENING MANAGEMENT COLPOSCOPY PATHOLOGIC DIAGNOSIS AND TREATMENT

PRE TEST CERVICAL SCREENING MANAGEMENT COLPOSCOPY PATHOLOGIC DIAGNOSIS AND TREATMENT PRE TEST CERVICAL SCREENING MANAGEMENT COLPOSCOPY PATHOLOGIC DIAGNOSIS AND TREATMENT QUESTION #1 WHICH OF THE FOLLOWING IS NOT A RISK FACTOR FOR CERVICAL CANCER? A. HIGH RISK HPV B. CIGARETTE SMOKING C.

More information

A clinical review of borderline glandular cells on cervical cytology

A clinical review of borderline glandular cells on cervical cytology British Journal of Obstetrics and Gynaecology May 2000, Vol07, pp. 605-609 A clinical review of borderline glandular cells on cervical cytology D. Kusnah A. Mohammed Research Senior House Oflcer, Ofer

More information

CERVICAL INTRAEPITHELIAL NEOPLASIA (CIN)

CERVICAL INTRAEPITHELIAL NEOPLASIA (CIN) CERVICAL INTRAEPITHELIAL NEOPLASIA (CIN) The cervix constitutes the lower third of the uterus. It is in two parts, the endocervix and the ectocervix. Ectocervix is covered with squamous epithelium. Endocervix

More information

Cytology Update M Laing QEUH

Cytology Update M Laing QEUH Cytology Update M Laing QEUH Age change to 25 to 65 Age 25 to 50 Three yearly smear invitation Age 50 to 65 Five yearly smear invitation Women on non routine screening will be invited up to age 70 OUTCOME

More information

Colposcopic Principles. Simon Leeson Consultant Obstetrician/ Gynaecologist Betsi Cadwaladr University Health Board UK

Colposcopic Principles. Simon Leeson Consultant Obstetrician/ Gynaecologist Betsi Cadwaladr University Health Board UK Colposcopic Principles Simon Leeson Consultant Obstetrician/ Gynaecologist Betsi Cadwaladr University Health Board UK The cervix topics discussed are: original squamous epithelium endocervical epithelium

More information

Effect of margin status on cervical intraepithelial neoplasia recurrence following LLETZ in women over 50 years

Effect of margin status on cervical intraepithelial neoplasia recurrence following LLETZ in women over 50 years DOI: 10.1111/j.1471-0528.2008.01853.x www.blackwellpublishing.com/bjog Gynaecological oncology Effect of margin status on cervical intraepithelial neoplasia recurrence following LLETZ in women over 50

More information

LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L14

LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L14 LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L4 ID LABEL HERE ---> - - - VISIT #: FORM COMPLETED BY: VERSION DATE: 08/5/94 ANY MISSING OR INCOMPLETE TEST RESULTS MUST BE EXPLAINED ON THIS FORM.

More information

A clinical review of borderline glandular cells reported on liquid-based cervical cytology

A clinical review of borderline glandular cells reported on liquid-based cervical cytology DOI: 10.1111/j.1471-0528.2009.02477.x www.bjog.org Gynaecological oncology A clinical review of borderline glandular cells reported on liquid-based cervical cytology A Patel, a N Thampy, b D Hemming, b

More information

Dysplasia: layer of the cervical CIN. Intraepithelial Neoplasia. p16 immunostaining. 1, Cervical. Higher-risk, requires CIN.

Dysplasia: layer of the cervical CIN. Intraepithelial Neoplasia. p16 immunostaining. 1, Cervical. Higher-risk, requires CIN. CLINICAL PRACTICE GUIDELINE Guideline Number: DHMP_DHMC_PG1015 Guideline Subject: Routine Cervical Cancer Screening Effective Date: 9/2018 Revision Date: 9/2019 Pages: 2 of 2 Quality Management Committee

More information

Department of Pathology, Kathmandu Medical College & Teaching Hospital, Sinamangal, Kathmandu, Nepal

Department of Pathology, Kathmandu Medical College & Teaching Hospital, Sinamangal, Kathmandu, Nepal Kathmandu University Medical Journal (2007), Vol. 5, No. 4, Issue 20, 461-467 Original Article Correlation of PAP smear findings with clinical findings and cervical biopsy Pradhan B 1, Pradhan SB 2, Mital

More information

Managament of Abnormal Cervical Cytology and Histology

Managament of Abnormal Cervical Cytology and Histology Managament of Abnormal Cervical Cytology and Histology Ali Ayhan, M.D Başkent University Faculty of Medicine Department of Gynecology and Obstetrics Division of Gynecologic Oncology Abnormal Cytologic

More information

WOMEN S INTERAGENCY HIV STUDY LABORATORY - PELVIC EXAM STUDIES TREATMENT FORM FORM L16

WOMEN S INTERAGENCY HIV STUDY LABORATORY - PELVIC EXAM STUDIES TREATMENT FORM FORM L16 WOMEN S INTERAGENCY HIV STUDY LABORATORY - PELVIC EXAM STUDIES TREATMENT FORM FORM L16 ID LABEL HERE ---> - - - VISIT #: FORM COMPLETED BY: VERSION DATE: 05/01/95 ANY MISSING OR INCOMPLETE TEST RESULTS

More information

,,,,, PATHOLOGY QUIZ PATHOLOGY Q U I Z

,,,,, PATHOLOGY QUIZ PATHOLOGY Q U I Z ,,,,, PATHOLOGY Q U I Z,,,,, PATHOLOGY QUIZ CASE HISTORY Alex Ferenczy, MD, Professor of Pathology and Obstetries and Gynaecology, The Sir Mortimer B. Davis ]ewish General HosPital, McGill University This

More information

Cervical Cancer : Pap smear

Cervical Cancer : Pap smear Taking a PAP SMEAR Cervical Cancer : Pap smear George N Papanicolaou introduced cervical cytology in clinical practice in 1940 In 1945, PAP smear was endorsed by American cancer society as an effective

More information

Pap Smears Pelvic Examinations Well Woman Examinations. When should you have them performed???

Pap Smears Pelvic Examinations Well Woman Examinations. When should you have them performed??? Pap Smears Pelvic Examinations Well Woman Examinations. When should you have them performed??? Arlene Evans-DeBeverly, PA-C Copyright 2012 There are always ongoing changes in gynecology, including the

More information

Study Number: Title: Rationale: Phase: Study Period Study Design: Centres: Indication Treatment: Objectives: Primary Outcome/Efficacy Variable:

Study Number: Title: Rationale: Phase: Study Period Study Design: Centres: Indication Treatment: Objectives: Primary Outcome/Efficacy Variable: The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.

More information

POST-CONIZATION FOLLOW-UP OF PATIENTS WITH HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESION TREATED BY LEEP PROCEDURE: A LITERATURE REVIEW

POST-CONIZATION FOLLOW-UP OF PATIENTS WITH HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESION TREATED BY LEEP PROCEDURE: A LITERATURE REVIEW POST-CONIZATION FOLLOW-UP OF PATIENTS WITH HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESION TREATED BY LEEP PROCEDURE: A LITERATURE REVIEW Boureima Ali Nafissatou and Dong zhao * Department of Gynecology, Shanghai

More information

Scottish Cervical Screening Programme. Colposcopy and Programme Management

Scottish Cervical Screening Programme. Colposcopy and Programme Management Scottish Cervical Screening Programme Colposcopy and Programme Management Addendum to NHSCSP Publication No 20 Second Edition Exceptions Applicable in NHS Scotland April 2013 (Final Version 2.8 to incorporate

More information

Eradicating Mortality from Cervical Cancer

Eradicating Mortality from Cervical Cancer Eradicating Mortality from Cervical Cancer Michelle Berlin, MD, MPH Vice Chair, Obstetrics & Gynecology Associate Director, Center for Women s Health June 2, 2009 Overview Prevention Human Papilloma Virus

More information

An audit of liquid-based cervical cytology screening samples (ThinPrep and SurePath) reported as glandular neoplasia

An audit of liquid-based cervical cytology screening samples (ThinPrep and SurePath) reported as glandular neoplasia DOI:10.1111/j.1365-2303.2009.00695.x An audit of liquid-based cervical cytology screening samples (ThinPrep and SurePath) reported as glandular neoplasia S. A. Thiryayi, J. Marshall and D. N. Rana Manchester

More information

Cervical Cancer Screening for the Primary Care Physician for Average Risk Individuals Clinical Practice Guidelines. June 2013

Cervical Cancer Screening for the Primary Care Physician for Average Risk Individuals Clinical Practice Guidelines. June 2013 Cervical Cancer Screening for the Primary Care Physician for Average Risk Individuals Clinical Practice Guidelines General Principles: Since its introduction in 1943, Papanicolaou (Pap) smear is widely

More information

Becoming a colposcopist: Colposcope case studies

Becoming a colposcopist: Colposcope case studies Becoming a colposcopist: Colposcope case studies Seon-Kyung Lee, M.D. Department of Obstetrics and Gynecology College of Medicine, Kyung Hee University Value of Colposcopy Cytology is an effective screening

More information

HKCOG GUIDELINES NUMBER 3 (revised November 2002) published by The Hong Kong College of Obstetricians and Gynaecologists

HKCOG GUIDELINES NUMBER 3 (revised November 2002) published by The Hong Kong College of Obstetricians and Gynaecologists HKCOG Guidelines Guidelines on the Management of An Abnormal Cervical Smear Number 3 revised November 2002 published by The Hong Kong College of Obstetricians and Gynaecologists A Foundation College of

More information

bleeding Studies naar de diagnostiek van endom triumcarcinoom bij vrouwen met postm nopauzaal bloedverlies. Studies on the

bleeding Studies naar de diagnostiek van endom triumcarcinoom bij vrouwen met postm nopauzaal bloedverlies. Studies on the Studies on the diagnosis of endometria cancer in women with postmenopausal bleeding. Studies naar de diagnostiek va endometriumcarcinoom bij vrouwen m postmenopauzaal bloedverlies. Studies on the diagnosis

More information

The LAST Guidelines in Clinical Practice. Implementing Recommendations for p16 Use

The LAST Guidelines in Clinical Practice. Implementing Recommendations for p16 Use AJCP / Original Article The LAST Guidelines in Clinical Practice Implementing Recommendations for p16 Use Lani K. Clinton, MD, PhD, 1,2 Kyle Miyazaki, 1 Asia Ayabe, 1 James Davis, PhD, 2 Pamela Tauchi-Nishi,

More information

A comparative study of two methods of large loop excision of the transformation zone

A comparative study of two methods of large loop excision of the transformation zone BJOG: an International Journal of Obstetrics and Gynaecology April 2005, Vol. 112, pp. 490 494 DOI: 10.1111/j.1471-0528.2005.00427.x A comparative study of two methods of large loop excision of the transformation

More information

International Federation of Gynecology and Obstetrics

International Federation of Gynecology and Obstetrics International Federation of Gynecology and Obstetrics Treatment of Cervical Precancerous Lesions using Thermocoagulation(Cold Coagulation) and Cryotherapy General Principles All high grade CIN should be

More information

PREVENTION OF CERVICAL CANCER

PREVENTION OF CERVICAL CANCER PREVENTION OF CERVICAL CANCER Author: Dr R. Fuentes MBchb, Havana Spec. OB,GY-Havana- 2011 CONTENT TABLE Abbreviations 2 Introduction 4 The natural history of Cervical cancer 4 Risk Factors 4 Incidence

More information

Screening for the Precursors of Cervical Cancer in the Era of HPV Vaccination. Dr Stella Heley Senior Liaison Physician Victorian Cytology Service

Screening for the Precursors of Cervical Cancer in the Era of HPV Vaccination. Dr Stella Heley Senior Liaison Physician Victorian Cytology Service Screening for the Precursors of Cervical Cancer in the Era of HPV Vaccination Dr Stella Heley Senior Liaison Physician Victorian Cytology Service Victorian Cytology Service Dr Stella Heley Dr Siobhan Bourke

More information

Cervical Cancer Screening. David Quinlan December 2013

Cervical Cancer Screening. David Quinlan December 2013 Cervical Cancer Screening David Quinlan December 2013 Cervix Cervical Cancer Screening Modest variation provincially WHO and UK begin at 25 stop at 60 Finland begin at 30 stop at 60 Rationale for

More information

Fluorescence Spectroscopy: A New Approach in Cervical Cancer

Fluorescence Spectroscopy: A New Approach in Cervical Cancer DOI 10.1007/s13224-012-0298-6 ORIGINAL ARTICLE : A New Approach in Cervical Cancer Pandey Kiran Pradhan Asima Agarwal Asha Bhagoliwal Ajay Agarwal Nidhi Received: 2 June 2008 / Accepted: 7 August 2012

More information

Completeness of excision and follow up cytology in patients treated with loop excision biopsy

Completeness of excision and follow up cytology in patients treated with loop excision biopsy J Clin Pathol ;:9 9 9 Department of Pathology, Mayday University Hospital, London Road, Thornton Heath, Surrey CR7 7YE, UK A M Zaitoun M J Coppen S M Thomas Department of Pathology, The Royal Surrey County

More information

HPV and Cervical Cancer, Screening and Prevention. John Ragsdale, MD July 12, 2018 CME Lecture Series

HPV and Cervical Cancer, Screening and Prevention. John Ragsdale, MD July 12, 2018 CME Lecture Series HPV and Cervical Cancer, Screening and Prevention John Ragsdale, MD July 12, 2018 CME Lecture Series We have come a long Way Prevalence HPV in Young Adults in U.S HPV genotypes 55-60% of All cancers 20%

More information

Histopathology: Cervical HPV and neoplasia

Histopathology: Cervical HPV and neoplasia Histopathology: Cervical HPV and neoplasia These presentations are to help you identify basic histopathological features. They do not contain the additional factual information that you need to learn about

More information

I have no financial interests to disclose.

I have no financial interests to disclose. Workshop: Case Management of Abnormal Pap Smears and Colposcopies Rebecca Jackson, MD Professor Obstetrics, Gynecology & Reproductive Sciences and Epidemiology & Biostatistics I have no financial interests

More information

To further assess abnormalities detected on cervical cytological sample. To guide colposcopically directed biopsy

To further assess abnormalities detected on cervical cytological sample. To guide colposcopically directed biopsy 1 To further assess abnormalities detected on cervical cytological sample To guide colposcopically directed biopsy To exclude invasive disease To aid in outpatient management and treatment of precancerous

More information

Associate Professor of Gyn. & Obs., Department of Gynecology and Obstetrics, Tehran University of Medical Sciences, Iran.

Associate Professor of Gyn. & Obs., Department of Gynecology and Obstetrics, Tehran University of Medical Sciences, Iran. Assessment of Visual Inspection with Acetic Acid (VIA) as a Screening Test for Cervical Neoplasia in Comparison with Cytologic Screening in Imam Khomeini Hospital F. Ghaemmaghami, MD Associate Professor

More information

GUIDELINE FOR SCREENING FOR CERVICAL CANCER: REVISED

GUIDELINE FOR SCREENING FOR CERVICAL CANCER: REVISED GUIDELINE FOR SCREENING FOR CERVICAL CANCER: REVISED This guideline is a revised version of the guideline developed in February 2000, by the Cervical Cancer Screening Working Group. This revised version

More information

THE NEW ZEALAND MEDICAL JOURNAL

THE NEW ZEALAND MEDICAL JOURNAL THE NEW ZEALAND MEDICAL JOURNAL Vol 8 No ISSN 75 876 Findings and outcome of teenage women referred for colposcopy at Christchurch Women s Hospital, New Zealand Peter Sykes, Dianne Harker, David Peddie

More information

Outcomes for women without conventional treatment for stage 1A (microinvasive) carcinoma of the cervix

Outcomes for women without conventional treatment for stage 1A (microinvasive) carcinoma of the cervix Aust N Z J Obstet Gynaecol 2018; 58: 321 329 DOI: 10.1111/ajo.12753 ORIGINAL ARTICLE Outcomes for women without conventional treatment for stage 1A (microinvasive) carcinoma of the cervix Charlotte Paul

More information

Objectives. I have no financial interests in any product I will discuss today. Cervical Cancer Screening Guidelines: Updates and Controversies

Objectives. I have no financial interests in any product I will discuss today. Cervical Cancer Screening Guidelines: Updates and Controversies Cervical Cancer Screening Guidelines: Updates and Controversies I have no financial interests in any product I will discuss today. Jody Steinauer, MD, MAS University of California, San Francisco Objectives

More information

EU guidelines for reporting gynaecological cytology

EU guidelines for reporting gynaecological cytology EU guidelines for reporting gynaecological cytology Amanda Herbert Guy s & St Thomas Foundation NHS Trust 5th EFCS Annual Tutorial, Trondheim, Norway 28 th May 1 st June 2012 EU guidelines aim to harmonize

More information

LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L14

LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L14 LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L4 ID LABEL HERE ---> - - - VISIT #: FORM COMPLETED BY: VERSION DATE: 09/5/95 ANY MISSING OR INCOMPLETE TEST RESULTS MUST BE EXPLAINED ON THIS FORM.

More information

Updated ASCCP Consensus Guidelines For Managing Diagnosed Cervical Cancer Precursors Michael A. Gold, M.D.

Updated ASCCP Consensus Guidelines For Managing Diagnosed Cervical Cancer Precursors Michael A. Gold, M.D. Updated ASCCP Consensus Guidelines For Managing Diagnosed Cervical Cancer Precursors Michael A. Gold, M.D. 27 May, 2014 London, England Faculty Disclosure X No, nothing to disclose Yes, please specify

More information

Cervical cancer is the leading cause of cancer death in

Cervical cancer is the leading cause of cancer death in Effect of on Visual Inspection With Acetic Acid Carol A. Davis-Dao, MS, 1 Miriam Cremer, MD, MPH, 2 Juan Felix, MD, 3 and Victoria K. Cortessis, PhD 1 1 Department of Preventive Medicine, University of

More information

Acceptable predictive accuracy of histopathology results by colposcopy done by Gynecology residents using Reid index

Acceptable predictive accuracy of histopathology results by colposcopy done by Gynecology residents using Reid index DOI 10.1007/s00404-012-2569-y GYNECOLOGIC ONCOLOGY Acceptable predictive accuracy of histopathology results by colposcopy done by Gynecology residents using Reid index Hadi Shojaei Fariba Yarandi Leila

More information

Vaginal intraepithelial neoplasia

Vaginal intraepithelial neoplasia Vaginal intraepithelial neoplasia The terminology and pathology of VAIN are analogous to those of CIN (VAIN I-III). The main difference is that vaginal epithelium does not normally have crypts, so the

More information

Video Workshop Cervical cancer screening as a multidisciplinary process

Video Workshop Cervical cancer screening as a multidisciplinary process Video Workshop Cervical cancer screening as a multidisciplinary process Dr. Amanda Herbert (Guy s & St Thomas NHS Foundation Trust, London) Professor Jaroslava Duskova (Charles University, Prague, Czech

More information

Your Colposcopy Visit

Your Colposcopy Visit Introduction Welcome to the colposcopy clinic. This booklet tells you about. The colposcopy examination.. Tests that are done in the colposcopy clinic.. What these tests look for Take a few minutes to

More information

VIN/VAIN O C T O B E R 3 RD J M O R G A N

VIN/VAIN O C T O B E R 3 RD J M O R G A N VIN/VAIN O C T O B E R 3 RD 2 0 1 8 J M O R G A N Vaginal Intraepithelial Neoplasia VAIN I, II, III Incidence 0.1/100,000 women in US Mean age 50s (J Womens Health (Larchmt) 2009:18:1731) (J Obstet Gynaecol

More information

Cervicovaginal Cytology: Normal and Abnormal Cells and Adequacy of Specimens

Cervicovaginal Cytology: Normal and Abnormal Cells and Adequacy of Specimens Cervicovaginal Cytology: Normal and Abnormal Cells and Adequacy of Specimens 3 Christine Bergeron, MD, PhD Introduction Carcinoma of the cervix is a slow growing cancer, which is preceded by precancerous

More information

SOGC / SCC Clinical Practice Guideline

SOGC / SCC Clinical Practice Guideline SOGC / SCC Clinical Practice Guideline Colposcopic Management of Abnormal Cervical Cancer Screening and Histology These Clinical Practice Guidelines have been prepared and approved by the Executive and

More information

1.Acute and Chronic Cervicitis - At the onset of menarche, the production of estrogens by the ovary stimulates maturation of the cervical and vaginal

1.Acute and Chronic Cervicitis - At the onset of menarche, the production of estrogens by the ovary stimulates maturation of the cervical and vaginal Diseases of cervix I. Inflammations 1.Acute and Chronic Cervicitis - At the onset of menarche, the production of estrogens by the ovary stimulates maturation of the cervical and vaginal squamous mucosa

More information

Gynaecological surgery. Introduction. MJ Camargo, a FB Russomano, a MA Trist~ao, a G Huf, b W Prendiville c

Gynaecological surgery. Introduction. MJ Camargo, a FB Russomano, a MA Trist~ao, a G Huf, b W Prendiville c DOI: 10.1111/1471-0528.13200 www.bjog.org Gynaecological surgery Large loop versus straight-wire excision of the transformation zone for treatment of cervical intraepithelial neoplasia: a randomised controlled

More information

Woo Dae Kang, Ho Sun Choi, Seok Mo Kim

Woo Dae Kang, Ho Sun Choi, Seok Mo Kim Is vaccination with quadrivalent HPV vaccine after Loop Electrosurgical Excision Procedure effective in preventing recurrence in patients with High-grade Cervical Intraepithelial Neoplasia (CIN2-3)? Chonnam

More information

Comparative Study of Pap Smear Quality by using Ayre s Spatula versus Ayre s Spatula and Cytobrush Combination

Comparative Study of Pap Smear Quality by using Ayre s Spatula versus Ayre s Spatula and Cytobrush Combination ORIGINAL ARTICLE Comparative Study of Pap Smear Quality by using Ayre s Spatula versus Ayre s Spatula and Cytobrush Combination Numi Anjum 1, B Sindhoora 2 1. Tutor, Department of Obstetrics and Gynecology

More information

Estimated New Cancers Cases 2003

Estimated New Cancers Cases 2003 Harvard-MIT Division of Health Sciences and Technology HST.071: Human Reproductive Biology Course Director: Professor Henry Klapholz Estimated New Cancers Cases 2003 Images removed due to copyright reasons.

More information

Disclosures. Learning objectives. George F. Sawaya, MD. I have nothing to disclose.

Disclosures. Learning objectives. George F. Sawaya, MD. I have nothing to disclose. Well Woman Visits in 2018: How Should We Approach Cervical Cancer Screening and Routine Pelvic Examinations? George F. Sawaya, MD Disclosures I have nothing to disclose. Professor, Obstetrics, Gynecology

More information

Cvtobrush and endocervical curettarre in the d$gnosis of dysplasia and rnalignaky of the uterine cervix

Cvtobrush and endocervical curettarre in the d$gnosis of dysplasia and rnalignaky of the uterine cervix ACIU Ohstrt Gj~17ewl Scuizrl 1997: 76: 69-73 Printed in Dmmurk - ull rights reserwd Cojniiqhf 0 4cto 0hrie.r Gi,ir~olScu,id1997 Acta Obstetricia et Gynecologica Scandinavica ISShi 0001-6349 ORIGINAL ARTICLE

More information

WOMEN S INTERAGENCY HIV STUDY LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L14

WOMEN S INTERAGENCY HIV STUDY LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L14 WOMEN S INTERAGENCY HIV STUDY LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L4 ID LABEL HERE ---> - - - VISIT #: FORM COMPLETED BY: VERSION DATE: 0 / 0 / 6 ANY MISSING OR INCOMPLETE TEST RESULTS

More information

Cervical Screening Results Leading to Detection of Adenocarcinoma in Situ of the Uterine Cervix

Cervical Screening Results Leading to Detection of Adenocarcinoma in Situ of the Uterine Cervix DOI:10.31557/APJCP.2019.20.2.377 Cervical Screening Results Leading to Detecting Cervical AIS RESEARCH ARTICLE Editorial Process: Submission:09/27/2018 Acceptance:01/18/2019 Cervical Screening Results

More information

BC Cancer Cervix Screening 2015 Program Results. February 2018

BC Cancer Cervix Screening 2015 Program Results. February 2018 BC Cancer Cervix Screening 2015 Program Results BC Cancer Cervix Screening 2015 Program Results 2 Table of Contents BC Cancer Cervix Screening 2015 Program Results... 1 Table of Contents... 2 Program Overview...

More information

LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L14

LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L14 LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L4 ID LABEL HERE ---> - - - VISIT #: FORM COMPLETED BY: VERSION DATE: 0/0/0 ANY MISSING OR INCOMPLETE TEST RESULTS MUST BE EXPLAINED ON THIS FORM.

More information

Molecular markers for diagnosis and prognosis in cervical neoplasia Eijsink, Jasper Johannes Hendrikus

Molecular markers for diagnosis and prognosis in cervical neoplasia Eijsink, Jasper Johannes Hendrikus University of Groningen Molecular markers for diagnosis and prognosis in cervical neoplasia Eijsink, Jasper Johannes Hendrikus IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's

More information

Introduction to Colposcopy

Introduction to Colposcopy Introduction to Colposcopy Papanicolaou smear (Pap smear) screening test Colposcopy diagnostic test Introduction to Colposcopy Acetic acid and Lugol s iodine applied Cervix examined under magnification

More information

Pap test results FOR WOMEN WITH AN ABNORMAL PAP TEST

Pap test results FOR WOMEN WITH AN ABNORMAL PAP TEST Pap test results FOR WOMEN WITH AN ABNORMAL PAP TEST Introduction This booklet provides women with information about abnormal Pap test results. Many women feel anxious or worried when they are told their

More information

Int J Clin Exp Med 2015;8(2): /ISSN: /IJCEM Yan Chen, Jia-De Zhou

Int J Clin Exp Med 2015;8(2): /ISSN: /IJCEM Yan Chen, Jia-De Zhou Int J Clin Exp Med 2015;8(2):2447-2452 www.ijcem.com /ISSN:1940-5901/IJCEM0003911 Original Article Application value of different transformation zone types and its genetic relationship with high-risk HPV

More information

A Randomized, Double-Blind, Placebo-Controlled Trial of 5-Fluorouracil for the Treatment of Cervicovaginal Human Papillomavirus

A Randomized, Double-Blind, Placebo-Controlled Trial of 5-Fluorouracil for the Treatment of Cervicovaginal Human Papillomavirus Infectious Diseases in Obstetrics and Gynecology 7:186-189 (1999) (C) 1999 Wiley-Liss, Inc. A Randomized, Double-Blind, Placebo-Controlled Trial of 5-Fluorouracil for the Treatment of Cervicovaginal Human

More information

Cervical Cancer Prevention in the 21 st Century Changing Paradigms

Cervical Cancer Prevention in the 21 st Century Changing Paradigms Cervical Cancer Prevention in the 21 st Century Changing Paradigms Teresa M. Darragh, MD UCSF Departments of Pathology and Obstetrics, Gynecology & Reproductive Sciences Faculty Disclosures: Teresa M.

More information

Guidelines for Breast, Cervical and Colorectal Cancer Screening

Guidelines for Breast, Cervical and Colorectal Cancer Screening Guidelines for Breast, Cervical and Colorectal Cancer Screening Your recommendation counts. Talk to your patients about screening for cancer. CancerCare Manitoba provides organized, population-based screening

More information

Human Papillomavirus

Human Papillomavirus Human Papillomavirus Dawn Palaszewski, MD Assistant Professor of Obstetrics and Gynecology University of February 18, 2018 9:40 am Dawn Palaszewski, MD Assistant Professor Department of Obstetrics and

More information

Promoting Cervical Screening Information for Health Professionals. Cervical Cancer

Promoting Cervical Screening Information for Health Professionals. Cervical Cancer Promoting Cervical Screening Information for Health Professionals Cervical Cancer PapScreen Victoria Cancer Council Victoria 1 Rathdowne St Carlton VIC 3053 Telephone: (03) 635 5147 Fax: (03) 9635 5360

More information

Cervical Testing and Results Management. An Evidenced-Based Approach April 22nd, Debora Bear, MSN, MPH

Cervical Testing and Results Management. An Evidenced-Based Approach April 22nd, Debora Bear, MSN, MPH Cervical Testing and Results Management An Evidenced-Based Approach April 22nd, 2010 Debora Bear, MSN, MPH Assistant Medical Director for Planned Parenthood of New Mexico, Inc. Burden of cervical cancer

More information